These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11561119)
1. High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome. Ramos-Casals M; Font J; García-Carrasco M; Calvo J; Places L; Padilla O; Cervera R; Bowen MA; Lozano F; Ingelmo M Rheumatology (Oxford); 2001 Sep; 40(9):1056-9. PubMed ID: 11561119 [TBL] [Abstract][Full Text] [Related]
2. Pattern of soluble CD5 and CD6 lymphocyte receptors in critically ill patients with septic syndromes. Aibar J; Martínez-Florensa M; Castro P; Carrasco E; Escoda-Ferran C; Fernández S; Butjosa M; Hernández C; Rinaudo M; Lozano F; Nicolás JM J Crit Care; 2015 Oct; 30(5):914-9. PubMed ID: 26031813 [TBL] [Abstract][Full Text] [Related]
3. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790 [TBL] [Abstract][Full Text] [Related]
4. Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome. García-Carrasco M; Pizcueta P; Cervera R; Ramos-Casals M; Sisó A; de La Red G; Ingelmo M; Font J; Engel P Ann Rheum Dis; 2000 Apr; 59(4):297-9. PubMed ID: 10733478 [TBL] [Abstract][Full Text] [Related]
5. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features. Garcíc-Carrasco M; Font J; Filella X; Cervera R; Ramos-Casals M; Sisó A; Aymamí A; Ballesta AM; Ingelmo M Clin Exp Rheumatol; 2001; 19(4):411-5. PubMed ID: 11491496 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble CD44 in primary Sjögren's syndrome. Levesque MC; Mackin DA; Fleming JA; St Clair EW J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268 [TBL] [Abstract][Full Text] [Related]
7. BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Quartuccio L; Salvin S; Fabris M; Maset M; Pontarini E; Isola M; De Vita S Rheumatology (Oxford); 2013 Feb; 52(2):276-81. PubMed ID: 22879463 [TBL] [Abstract][Full Text] [Related]
9. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. Agmon-Levin N; Kivity S; Tzioufas AG; López Hoyos M; Rozman B; Efes I; Shapira Y; Shamis A; Amital H; Youinou P; Shoenfeld Y J Autoimmun; 2012 Sep; 39(3):234-9. PubMed ID: 22835660 [TBL] [Abstract][Full Text] [Related]
10. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome. Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497 [TBL] [Abstract][Full Text] [Related]
11. Activation antigens expressed on T-cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis. Ichikawa Y; Shimizu H; Yoshida M; Arimori S Clin Exp Rheumatol; 1990; 8(3):243-9. PubMed ID: 1974181 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to CD4 in primary Sjögren's syndrome. Henriksson G; Manthorpe R; Bredberg A Rheumatology (Oxford); 2000 Feb; 39(2):142-7. PubMed ID: 10725063 [TBL] [Abstract][Full Text] [Related]
13. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome. Thomsen BS; Oxholm P; Manthorpe R; Nielsen H Arthritis Rheum; 1986 Jul; 29(7):857-62. PubMed ID: 2943291 [TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome. Ichikawa Y; Arimori K; Yoshida M; Horiki T; Hoshina Y; Morita K; Uchiyama M; Shimizu H; Moriuchi J; Takaya M Clin Exp Rheumatol; 1995; 13(3):307-13. PubMed ID: 7554556 [TBL] [Abstract][Full Text] [Related]
15. Serum soluble adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) and neopterin in patients with Sjögren's syndrome. Andrýs C; Krejsek J; Slezák R; Drahosová M; Kopecký O Acta Medica (Hradec Kralove); 1999; 42(3):97-101. PubMed ID: 10677896 [TBL] [Abstract][Full Text] [Related]
16. The expression and function of CD3 and CD5 in patients with primary Sjögren's syndrome. Dauphinée MJ; Tovar Z; Ballester A; Talal N Arthritis Rheum; 1989 Apr; 32(4):420-9. PubMed ID: 2468337 [TBL] [Abstract][Full Text] [Related]
17. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome. Maria NI; van Helden-Meeuwsen CG; Brkic Z; Paulissen SM; Steenwijk EC; Dalm VA; van Daele PL; Martin van Hagen P; Kroese FG; van Roon JA; Harkin A; Dik WA; Drexhage HA; Lubberts E; Versnel MA Arthritis Rheumatol; 2016 Jul; 68(7):1688-99. PubMed ID: 26866723 [TBL] [Abstract][Full Text] [Related]
18. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome. van de Merwe JP; van den Beemd MW; Hooijkaas H Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444 [TBL] [Abstract][Full Text] [Related]
19. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Mariette X; Roux S; Zhang J; Bengoufa D; Lavie F; Zhou T; Kimberly R Ann Rheum Dis; 2003 Feb; 62(2):168-71. PubMed ID: 12525388 [TBL] [Abstract][Full Text] [Related]
20. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome]. Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]